Marini Matthew, Gutkind Sarah, Livne Ofir, Fink David S, Saxon Andrew J, Simpson Tracy L, Sherman Scott E, Mannes Zachary L
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.
J Gen Intern Med. 2025 Jan 3. doi: 10.1007/s11606-024-09320-6.
In the United States (U.S.), the prevalence of anxiety and depression is increasing, yet significant barriers to mental health treatment remain. U.S. military veterans are disproportionately affected by anxiety and depression. Many veterans receive medical care within the Veterans Health Administration (VHA), an integrated healthcare system that has enacted clinical initiatives to reduce barriers to mental health treatment.
We examined associations between VHA healthcare use and receipt of mental health counseling or prescription medication for anxiety or depression.
Cross-sectional nationally representative study.
U.S. veterans aged ≥ 18 years with past 12-month healthcare use and anxiety or depression (N = 1,161).
In the 2019 National Health Interview Survey, veterans were assessed for their use of the VHA (vs. non-VHA healthcare use) and receipt of past 12-month mental health counseling, prescription medication for anxiety, or prescription medication for depression.
Among all veterans with anxiety or depression, only 23% received mental health counseling, while 26% and 23% received prescription medication for anxiety or depression, respectively. Compared to non-VHA veterans, VHA patients were more likely to receive counseling (adjusted odds ratio [aOR] = 6.28, 95% CI: 5.33, 7.40), and prescription medication for anxiety (aOR = 2.03, 95% CI: 1.72, 2.40), or depression (aOR = 2.54, 95% CI: 2.17, 2.97).
Among veterans with anxiety or depression, VHA patients were more likely to receive mental health treatment than non-VHA veterans. Findings suggest that veteran use of counseling and psychiatric interventions remains limited, though the integrated healthcare system of the VHA may facilitate access to mental health treatment and provides a framework for non-VHA medical centers to expand access to and improve delivery of mental health services.
在美国,焦虑症和抑郁症的患病率正在上升,但心理健康治疗仍存在重大障碍。美国退伍军人受焦虑症和抑郁症的影响尤为严重。许多退伍军人在退伍军人健康管理局(VHA)接受医疗护理,这是一个综合医疗系统,已制定临床举措以减少心理健康治疗的障碍。
我们研究了VHA医疗保健使用与接受焦虑或抑郁症心理健康咨询或处方药之间的关联。
全国性横断面代表性研究。
年龄≥18岁、过去12个月使用过医疗保健服务且患有焦虑症或抑郁症的美国退伍军人(N = 1161)。
在2019年全国健康访谈调查中,评估退伍军人对VHA的使用情况(与非VHA医疗保健使用情况相比)以及过去12个月接受心理健康咨询、焦虑症处方药或抑郁症处方药的情况。
在所有患有焦虑症或抑郁症的退伍军人中,只有23%接受了心理健康咨询,而分别有26%和23%接受了焦虑症或抑郁症的处方药治疗。与非VHA退伍军人相比,VHA患者更有可能接受咨询(调整后的优势比[aOR]=6.28,95%置信区间:5.33,7.40),以及焦虑症处方药治疗(aOR = 2.03,95%置信区间:1.72,2.40)或抑郁症处方药治疗(aOR = 2.54,95%置信区间:2.17,2.97)。
在患有焦虑症或抑郁症的退伍军人中,VHA患者比非VHA退伍军人更有可能接受心理健康治疗。研究结果表明,退伍军人对咨询和精神科干预的使用仍然有限,尽管VHA的综合医疗系统可能有助于获得心理健康治疗,并为非VHA医疗中心扩大心理健康服务的可及性和改善服务提供了一个框架。